ArticleScientific reports2025
Multilevel support-assisted prototype optimization network for few-shot medical segmentation of lung lesions.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quantifying the Resolution Ceiling of Prototype-Based Few-Shot Segmentation on Sub-Centimetre Pulmonary Nodules: A Training-Free Geometric Analysis.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medical image annotation is scarce and costly. Few-shot segmentation has been widely used in medical image from only a few annotated examples. However, its research on lesion segmentation for lung diseases is still limited, especially for pulmonary aspergillosis. Lesion areas usually have complex shapes and blurred edges. Lesion segmentation requires more attention to deal with the diversity and uncertainty of lesions. To address this challenge, we propose MSPO-Net, a multilevel support-assisted prototype optimization network designed for few-shot lesion segmentation in computerized tomography (CT) images of lung diseases. MSPO-Net learns lesion prototypes from low-level to high-level features. Self-attention threshold learning strategy can focus on the global information and obtain an optimal threshold for CT images. Our model refines prototypes through a support-assisted prototype optimization module, adaptively enhancing their representativeness for the diversity of lesions and adapting to the unseen lesions better. In clinical examinations, CT is more practical than X-rays. To ensure the quality of our work, we have established a small-scale CT image dataset for three lung diseases and annotated by experienced doctors. Experiments demonstrate that MSPO-Net can improve segmentation performance and robustness of lung disease lesion. MSPO-Net achieves state-of-the-art performance in both single and unseen lung disease segmentation, indicating its potentiality to reduce doctors' workload and improve diagnostic accuracy. This research has certain clinical significance. Code is available at https://github.com/Tian-Yuan-ty/MSPO-Net .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.